ESR1 and breast cancer: Previously, we had determined expression of seven different phosphorylated residues on ERα in these same breast cancer samples from patients who subsequently received adjuvant tamoxifen therapy, and found that multiple tumors expressed combinations of phosphorylated ERα epitopes [5,6].